1. Ward DJ, Connolly DJ, Griffiths PD. Review of the MRI brain findings of septo-optic dysplasia. Clin Radiol. 2021; 76:160. e1-14.
Article
2. Webb EA, Dattani MT. Septo-optic dysplasia. Eur J Hum Genet. 2010; 18:393–7.
Article
3. Kelberman D, Dattani MT. Genetics of septo-optic dysplasia. Pituitary. 2007; 10:393–407.
Article
4. Miller DT, Shen Y, Weiss LA, Korn J, Anselm I, Bridgemohan C, et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet. 2009; 46:242–8.
Article
5. Lowther C, Costain G, Stavropoulos DJ, Melvin R, Silversides CK, Andrade DM, et al. Delineating the 15q13.3 microdeletion phenotype: a case series and comprehensive review of the literature. Genet Med. 2015; 17:149–57.
Article
6. Sinkus ML, Graw S, Freedman R, Ross RG, Lester HA, Leonard S. The human CHRNA7 and CHRFAM7A genes: a review of the genetics, regulation, and function. Neuropharmacology. 2015; 96(Pt B):274–88.
Article
7. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009; 89:73–120.
Article
8. Ross RG, Stevens KE, Proctor WR, Leonard S, Kisley MA, Hunter SK, et al. Research review: cholinergic mechanisms, early brain development, and risk for schizophrenia. J Child Psychol Psychiatry. 2010; 51:535–49.
Article
9. Szafranski P, Schaaf CP, Person RE, Gibson IB, Xia Z, Mahadevan S, et al. Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological? Hum Mutat. 2010; 31:840–50.
Article
10. Xie Y. Is chromosome 15q13.3 duplication involving CHRNA7 associated with oral clefts? Child Neurol Open. 2015; 2:2329048X15618918.
Article
11. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Mårtensson IL, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet. 1998; 19:125–33.
Article
12. Hagstrom SA, Pauer GJ, Reid J, Simpson E, Crowe S, Maumenee IH, et al. SOX2 mutation causes anophthalmia, hearing loss, and brain anomalies. Am J Med Genet A. 2005; 138A:95–8.